Rationale and design of switch Swedeheart: A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
Elmir Ömerovic(Sahlgrenska University Hospital), Björn Redfors(Cornell University), Max Petzold(University of Gothenburg), Charlotta Ljungman(Swedish Academy), Kristian Bolin(University of Gothenburg), Ole Fröbert(Aarhus University), Robert Kastberg(Östersunds Hospital), David Erlinge(Lund University), Jonas Andersson(Skellefteå Hospital), J. Pontén(Hallands sjukhus Halmstad), Sasha Koul(Lund University), Fredrik Björklund(Lund University)
Cited by 18
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis
|The Lancet Global Health|2018|3.1k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k